| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |